In summary, our data illustrate that the knockdown of RAB31 can reduce the enrichment of MYO1C in extracellular vesicles, thereby attenuating the promotion of glioma cell invasion by GhEC‐EVs. This evidence concerns the gene MYO1C and central nervous system cancer.